To ask the Secretary of State for the Home Department, with reference to the oral contribution of the Minister for Policing, Crime and Criminal Justice, of 12 October 2015, Official Report, columns 32-36, what discussions she has (a) had and (b) plans to have with (i) her counterparts in other Government Departments and (ii) the pharmaceutical industry on the medical evidence and research that exists on the use of cannabis for medical treatment; and if she will make a statement.
26 October 2015
The Government’s position on the medicinal value of cannabis remains unchanged and no discussions are planned. The Medicines and Healthcare products Regulatory Agency is open to considering marketing approval applications for further cannabis-based medicinal products.
The Home Office will continue to consider applications for Schedule 1 licences on their merits to enable trials of new medicines, subject to the appropriate ethical approvals where human trials are envisaged. The Misuse of Drugs Act 1971, and regulations made under the Act, continue to facilitate research in this area.